Piśmiennictwo
1. Yu J. Endocrine disorders and the neurologic manifestations. Ann Pediatr Endocrinol Metab 2014;19:184-90.
2. Musumeci G, Castorina S, Castrogiovanni P, et al. A journey through the pituitary gland: development, structure and function, with emphasis on embryo-foetal and later development. Acta Histochem 2015;117:355-66.
3. Sasagawa Y, Tachibana O, Doai M, et al. Median nerve conduction studies and wrist magnetic resonance imaging in acromegalic patients with carpal tunnel syndrome. Pituitary 2015 Feb 8 [Epub ahead of print].
4. Baldys-Waligorska A, Krzentowska A, Golkowski F, et al. The prevalence of benign and malignant neoplasms in acromegalic patients. Endokrynol Pol 2010;61:29-34.
5. Bolanowski M, Ruchala M, Zgliczynski W, et al. Acromegaly – a novel view of the patient. Polish proposals for diagnostic and therapeutic procedures in the light of recent reports. Endokrynol Pol 2014;65:326-31.
6. Bolanowski M, Zatonska K, Kaluzny M, et al. A follow-up of 130 patients with acromegaly in a single centre. Neuro Endocrinol Lett 2006;27:828-32.
7. Tseng CH, Liao CC, Kuo CM, et al. Medical and non-medical correlates of carpal tunnel syndrome in a Taiwan cohort of one million. Eur J Neurol 2012;19:91-7.
8. Tagliafico A, Resmini E, Ferone D, et al. Musculoskeletal complications of acromegaly: what radiologists should know about early manifestations. Radiol Med 2011;116:781-92.
9. Pearce JM. On the Origins of Pituitary Apoplexy. Eur Neurol 2015;74:18-21.
10. Roerink SH, van Lindert EJ, van de Ven AC. Spontaneous remission of acromegaly and Cushing’s disease following pituitary apoplexy: Two case reports. Neth J Med 2015;73:242-6.
11. Styk A, Zielinski G. Pituitary apoplexy – not always correctly recognized life-threatening entity. Pol Merkur Lekarski 2015;38:340-3.
12. Watson JC, Dyck PJ. Peripheral Neuropathy: A Practical Approach to Diagnosis and Symptom Management. Mayo Clin Proc 2015;90:940-51.
13. Merashli M, Chowdhury TA, Jawad AS. Musculoskeletal manifestations of diabetes mellitus. QJM 2015 May 28. pii: hcv106. [Epub ahead of print].
14. Mulder L, Onur O, Kleis L, et al. Atypical neurologic presentations of new onset type 1 diabetes mellitus in pediatric age group: a report of five unusual cases and review of the literature. J Pediatr Endocrinol Metab 2014;27:749-56.
15. Villar J, Finol HJ, Torres SH, et al. Myopathy in patients with Hashimoto’s disease. Invest Clin 2015;56:33-46.
16. Tsang CC, Hui WS, Lo KM, et al. Anti-thyroid drugs-related myopathy: is carbimazole the real culprit? Int J Endocrinol Metab 2015 Jan;13(1):e17570.
17. De Groot LJ, Bartalena L. Thyroid Storm. In: De Groot LJ, Beck-Peccoz P, Chrousos G, et al. (editors). Source Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc;2000-2015 Apr 12.
18. Ruchala M, Szczepanek E, Tamborska-Zedlewska M, et al. Congenital hypothyroidism simulating acromegaly – a diagnostic pitfall. Neuro Endocrinol Lett 2009;30:322-6.
19. Shi X, Sun Y, Qiang R. Undiagnosed congenital hypothyroidism in a newborn treated with dopamine infusion. J Trop Pediatr 2015;61:215-7.
20. Jbara Y, Bricker D. Rhabdomyolysis in the setting of induced hypothyroidism and statin therapy: a case report. Eur Thyroid J 2015;4:62-4.
21. Shiri R. Hypothyroidism and carpal tunnel syndrome: a meta-analysis. Muscle Nerve 2014;50:879-83.
22. Ittermann T, Volzke H, Baumeister SE, et al. Diagnosed thyroid disorders are associated with depression and anxiety. Soc Psychiatry Psychiatr Epidemiol 2015 Mar 17. [Epub ahead of print].
23. Wiersinga WM. Myxedema and Coma (Severe Hypothyroidism). In: De Groot LJ, Beck-Peccoz P, Chrousos G, et al. (editors). Source Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.;2000-2012 Jul 21.
24. Pyzik A, Grywalska E, Matyjaszek-Matuszek B, et al. Immune disorders in Hashimoto’s thyroiditis: what do we know so far? J Immunol Res 2015;979167.
25. Ruchala M, Szczepanek E, Skiba A, et al. Graves’ hyperthyroidism following primary hypothyroidism due to Hashimoto’s thyroiditis in a case of thyroid hemiagenesis: case report. Neuro Endocrinol Lett 2008;29:55-8.
26. Ruchala M, Kosowicz J, Baumann-Antczak A, et al. The prevalence of autoantibodies to: myosin, troponin, tropomyosin and myoglobin in patients with circulating triiodothyronine and thyroxine autoantibodies (THAA). Neuro Endocrinol Lett 2007;28:259-66.
27. Tagoe CE. Rheumatic symptoms in autoimmune thyroiditis. Curr Rheumatol Rep 2015;17:5.
28. Robles-Cedeno R, Gich J, Genis Batlle D, et al. Rapidly progressive dementia with false-positive PCR Tropheryma whipplei in CSF. A case of Hashimoto’s encephalopathy. J Neurol Sci 2015;355:213-5.
29. Bono G, Fancellu R, Blandini F, et al. Cognitive and affective status in mild hypothyroidism and interactions with L-thyroxine treatment. Acta Neurol Scand 2004;110:59-66.
30. Czarnywojtek A, Zgorzalewicz-Stachowiak M, Stangierski A, et al. Thyroid associated orbitopathy – medication, radioiodine or operation? Przegl Lek 2012;69:1140-3.
31. Pivonello R, Simeoli C, De Martino MC, et al. Neuropsychiatric disorders in Cushing’s syndrome. Front Neurosci 2015 Apr 20;9:129. doi: 10.3389/fnins.2015.00129. eCollection 2015.9 129.
32. Raff H. Cushing syndrome: update on testing. Endocrinol Metab Clin North Am 2015;44(1):43-50. doi: 10.1016/j.ecl.2014.10.005.
33. Johannsson G, Falorni A, Skrtic S, et al. Adrenal insufficiency: review of clinical outcomes with current glucocorticoid replacement therapy. Clin Endocrinol (Oxf) 2015;82:2-11.
34. Abdelkefi M, Abdallah M, Larbi T, et al. Pseudo myopathy revealing primary hyperparathyroidism: a case report. Tunis Med 2014;92:766.
35. Cosci F, Fava GA, Sonino N. Mood and anxiety disorders as early manifestations of medical illness: a systematic review. Psychother Psychosom 2015;84:22-9.
36. Policepatil SM, Caplan RH, Dolan M. Hypocalcemic myopathy secondary to hypoparathyroidism. WMJ 2012;111:173-5.